| Clinical data | |
|---|---|
| Other names |
|
| Drug class | Sympathomimetic;β-Adrenergic receptor agonist;Positive inotrope;Positive chronotrope |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C18H23NO3 |
| Molar mass | 301.386 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Butopamine (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name; developmental code nameLY-131126; also known as(R,R)-ractopamine) is asympathomimetic agent,β-adrenergic receptoragonist, andpositive inotrope of thephenethylamine family which was studied for treatment ofheart failure but was never marketed.[1][2][3][4] It is ananalogue ofdobutamine[3][4] and is the (R,R)-enantiomer ofractopamine.[2] Butopamine is not acatecholamine and is resistant tometabolism bycatecholO-methyltransferase (COMT).[3] In contrast to dobutamine, butopamine isorally active.[3] In addition to its positive inotropic effects, butopamine haspositive chronotropic effects.[3]
Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byadding missing information. |